Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature
To investigate the possibility of a Hispanic mortality advantage, we conducted a systematic
review and meta-analysis of the published longitudinal literature reporting Hispanic …
review and meta-analysis of the published longitudinal literature reporting Hispanic …
[HTML][HTML] A review of HIV antiretroviral adherence and intervention studies among HIV–infected youth
MSL Reisner, MJ Mimiaga, MM Skeer… - Topics in HIV …, 2009 - ncbi.nlm.nih.gov
Advances in antiretroviral medications have resulted in precipitous declines in HIV-
associated morbidity and mortality; however, high levels of adherence are crucial to the …
associated morbidity and mortality; however, high levels of adherence are crucial to the …
[ΒΙΒΛΙΟ][B] Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach-2010 revision
World Health Organization - 2010 - apps.who.int
2010 revision Page 1 ANTIRETROVIRAL ThERApy fOR hIV INfEcTION IN INfANTs ANd
chILdREN: TOwARds uNIVERsAL AccEss Recommendations for a public health approach 2010 …
chILdREN: TOwARds uNIVERsAL AccEss Recommendations for a public health approach 2010 …
[ΒΙΒΛΙΟ][B] Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach
World Health Organization - 2004 - apps.who.int
The advent of potent antiretroviral therapy (ART) in 1996 led to a revolution in the care of
patients with HIV/AIDS in the developed world. Although the treatments are not a cure and …
patients with HIV/AIDS in the developed world. Although the treatments are not a cure and …
[HTML][HTML] Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the …
LM Mofenson, MT Brady, SP Danner… - MMWR Recomm …, 2009 - cdc.gov
This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …
Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection
PL Williams, D Storm, G Montepiedra, S Nichols… - …, 2006 - publications.aap.org
BACKGROUND. Most evaluations of adherence to antiretroviral therapy in children with HIV
infection have focused on validation of adherence measures via their association with …
infection have focused on validation of adherence measures via their association with …
Incidence of opportunistic and other infections in HIV-infected children in the HAART era
ContextCombination anti-retroviral therapy or highly active antiretroviral therapy (HAART)
has resulted in a dramatic decline in the incidence of opportunistic and other infections in …
has resulted in a dramatic decline in the incidence of opportunistic and other infections in …
Trends in the black-white life expectancy gap in the United States, 1983-2003
ContextSince the early 1980s, the black-white gap in life expectancy at birth increased
sharply and subsequently declined, but the causes of these changes have not been …
sharply and subsequently declined, but the causes of these changes have not been …
The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children
Background: The toxicity and complexity of antiretroviral therapy (ART) regimens are
substantial challenges in the context of patients' lives. This study examines child …
substantial challenges in the context of patients' lives. This study examines child …
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV
K Squires, A Lazzarin, JM Gatell… - JAIDS Journal of …, 2004 - journals.lww.com
Background: Atazanavir, an azapeptide protease inhibitor (PI), has pharmacokinetics that
allow once-daily dosing, and it is not associated with significant PI-associated dyslipidemia …
allow once-daily dosing, and it is not associated with significant PI-associated dyslipidemia …